Effect of prasugrel versus ticagrelor on coronary microperfusion in ST elevation myocardial infarction patients undergoing percutaneous coronary angioplasty - Acute and short term results
Guardado en:
Autores principales: | Rupesh Santosh Agrawal, Saibal Mukhopadhyay, Jamal Yusuf |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/171aa96ecce34975ad8859671f6669ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
por: Johny Nicolas, et al.
Publicado: (2020) -
Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Ziwei Xi, et al.
Publicado: (2021) -
Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
por: Gjin Ndrepepa, et al.
Publicado: (2021) -
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao L, et al.
Publicado: (2014) -
OUTCOMES OF TRANSRADIAL APPROACH IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
por: Amna Rashdi, et al.
Publicado: (2020)